Astman, N.; Arbel, C.; Katz, O.; Barzilai, A.; Solomon, M.; Schwartz, E.
Tolerability and Safety of Miltefosine for the Treatment of Cutaneous Leishmaniasis. Trop. Med. Infect. Dis. 2024, 9, 218.
https://doi.org/10.3390/tropicalmed9090218
AMA Style
Astman N, Arbel C, Katz O, Barzilai A, Solomon M, Schwartz E.
Tolerability and Safety of Miltefosine for the Treatment of Cutaneous Leishmaniasis. Tropical Medicine and Infectious Disease. 2024; 9(9):218.
https://doi.org/10.3390/tropicalmed9090218
Chicago/Turabian Style
Astman, Nadav, Chen Arbel, Oren Katz, Aviv Barzilai, Michal Solomon, and Eli Schwartz.
2024. "Tolerability and Safety of Miltefosine for the Treatment of Cutaneous Leishmaniasis" Tropical Medicine and Infectious Disease 9, no. 9: 218.
https://doi.org/10.3390/tropicalmed9090218
APA Style
Astman, N., Arbel, C., Katz, O., Barzilai, A., Solomon, M., & Schwartz, E.
(2024). Tolerability and Safety of Miltefosine for the Treatment of Cutaneous Leishmaniasis. Tropical Medicine and Infectious Disease, 9(9), 218.
https://doi.org/10.3390/tropicalmed9090218